Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?

Robust antigen point-of-care SARS-CoV-2 tests have been proposed as an efficient tool to address the COVID-19 pandemic. This requirement was raised after acknowledging the constraints that are brought by molecular biology. However, worldwide markets have been flooded with cheap and potentially under...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreani, Julien, Lupo, Julien, Germi, Raphaële, Laugier, Christel, Roccon, Marie, Larrat, Sylvie, Morand, Patrice, Nemoz, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376530/
https://www.ncbi.nlm.nih.gov/pubmed/34492569
http://dx.doi.org/10.1016/j.jcv.2021.104947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376530/
https://www.ncbi.nlm.nih.gov/pubmed/34492569
http://dx.doi.org/10.1016/j.jcv.2021.104947

Ejemplares similares